We found that the glioma cells presented a reduced proliferation capacity after gene intervention on CBX7 and CBX8, as indicated by the Ki67 immunostaining in vitro(Figure 6H;, Supplementary Figure S2A). This evidence concerns the gene MKI67 and glioma.